NextCure, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
4.07M
on 2026-06-30, from 2.33M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-12 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
$14.5M
H.C. Wainwright, agreement of 2025-12-19. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-06 is not read yet.
Cash
1.7 quarters
$15.3M on 2026-06-30 ÷ $9.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-07-14 | Private placement | not read | not read | $320.0M | 8-K ↗ |
| 2025-11-12 | Private placement incl. 1.82M pre-funded | 2,523,477 | $8.52 | $21.5M | 8-K ↗ |
| 2025-06-13 | Private placement | 4,063,633 | not read | $2.0M | 8-K ↗ |
Also on file: a 1-for-12 reverse split, 2025-07-14 8-K ↗